| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8656628 | Atherosclerosis | 2018 | 11 Pages |
Abstract
MK-2206 is a novel LDLR-inducing agent that, either alone or in combination with statins, exerts a stimulating effect on cellular LDL uptake.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Katrine Bjune, Hilde Sundvold, Trond P. Leren, Soheil Naderi,